Literature DB >> 9696897

Physiology of the chronic wound.

B C Nwomeh1, D R Yager, I K Cohen.   

Abstract

There is as yet no unified mechanism that explains the pathophysiology of every nonhealing wound. This is largely because many of the basic biological investigations in this area have only been undertaken seriously in the past few years and many phenomena remain unexplained. As new data become available, these theoretical models undoubtedly will continue to evolve. However, a clear understanding of the facts presently available should provide the clinician with a good scientific basis for rational clinical interventions. There is an urgent need to bridge the gap that often exists between laboratory research and clinical practice. A number of wound care practices, which have been shown to be ineffective or harmful, are still widely used. This includes the application of toxic wound cleansing agents, inappropriate use of topical antibiotics, and the practice of wet-to-dry dressings. The past 2 decades have witnessed an unprecedented proliferation of wound care products, few of which have be proven to be consistently superior to simpler and more cost-effective measures. For the foreseeable future, the search for the magic wound 'portions and lotions' probably will continue to revolve around topical growth factor and antiprotease therapy. However, such efforts will only come to fruition when we truly understand the pathophysiologic basis for abnormal wound healing.

Mesh:

Substances:

Year:  1998        PMID: 9696897

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  35 in total

Review 1.  Novel use of platelet-rich plasma to augment curative diabetic foot surgery.

Authors:  Christy L Scimeca; Manish Bharara; Timothy K Fisher; Heather Kimbriel; David G Armstrong
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Healing the diabetic wound and keeping it healed: modalities for the early 21st century.

Authors:  Matthew J Claxton; David G Armstrong; Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 3.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

4.  Negative pressure wound therapy as an adjunct in healing of chronic wounds.

Authors:  Vijay Langer; Prem S Bhandari; Satyamoorthy Rajagopalan; Mrinal K Mukherjee
Journal:  Int Wound J       Date:  2013-07-16       Impact factor: 3.315

5.  Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration.

Authors:  Vitali Alexeev; Julio Cesar Salas-Alanis; Francis Palisson; Lila Mukhtarzada; Giulio Fortuna; Jouni Uitto; Andrew South; Olga Igoucheva
Journal:  J Invest Dermatol       Date:  2017-07-20       Impact factor: 8.551

Review 6.  An audit to assess the perspectives of U.S. wound care specialists regarding the importance of proteases in wound healing and wound assessment.

Authors:  Robert J Snyder; Breda Cullen; Lorraine T Nisbet
Journal:  Int Wound J       Date:  2012-07-29       Impact factor: 3.315

7.  Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.

Authors:  M C Robson; D P Hill; P D Smith; X Wang; K Meyer-Siegler; F Ko; J S VandeBerg; W G Payne; D Ochs; L E Robson
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

8.  Immediate tight sealing of skin incisions using an innovative temperature-controlled laser soldering device: in vivo study in porcine skin.

Authors:  David Simhon; Marisa Halpern; Tamar Brosh; Tamar Vasilyev; Avi Ravid; Tamar Tennenbaum; Zvi Nevo; Abraham Katzir
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

9.  Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.

Authors:  José I Fernández-Montequín; Carmen M Valenzuela-Silva; Odalys González Díaz; William Savigne; Natasha Sancho-Soutelo; Fidel Rivero-Fernández; Pablo Sánchez-Penton; Lourdes Morejón-Vega; Heriberto Artaza-Sanz; Arístides García-Herrera; Cecilio González-Benavides; Carlos M Hernández-Cañete; Alberto Vázquez-Proenza; Jorge Berlanga-Acosta; Pedro A López-Saura
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

10.  Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.

Authors:  José I Fernández-Montequín; Ena Infante-Cristiá; Carmen Valenzuela-Silva; Neobalis Franco-Pérez; William Savigne-Gutierrez; Heriberto Artaza-Sanz; Lourdes Morejón-Vega; Cecilio González-Benavides; Osvaldo Eliseo-Musenden; Elizeth García-Iglesias; Jorge Berlanga-Acosta; Ricardo Silva-Rodríguez; Blas Y Betancourt; Pedro A López-Saura
Journal:  Int Wound J       Date:  2007-10-22       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.